| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |